Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Rehder

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Molecular Genetics and Metabolism|January 7, 2014
Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 geneDeeksha S Bali, Jennifer L Goldstein, Keri Fredrickson, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 19, 2012
Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniquesSarah P Young, Monique Piraud, Jennifer L Goldstein, et al.
American Journal of Clinical Pathology|December 12, 2017
Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 CasesBin Wu, Kimberly Ingersoll, Rachel Jug, et al.
The Journal of Pediatrics|October 14, 2019
Clinical and Molecular Disease Spectrum and Outcomes in Patients with Infantile-Onset Pompe DiseaseNeerja Gupta, Zoheb B Kazi, Sheela Nampoothiri, et al.
Human Pathology|February 26, 2014
Composite lymphoid neoplasm of B-cell and T-cell origins: a pathologic study of 14 casesEndi Wang, Paulie Papavassiliou, Alun R Wang, et al.
International Journal of Laboratory Hematology|April 13, 2021
Infantile leukemia-What factors determine its distinct biological nature? Clinicopathological study of 78 casesXin Liu, Yue Zhao, Catherine Luedke, et al.
American Journal of Clinical Pathology|March 18, 2011
Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literatureEndi Wang, Charles Blake Hutchinson, Qin Huang, et al.
Infection Control and Hospital Epidemiology|August 4, 2020
Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence areaSarah S Lewis, Becky A Smith, Ibukunoluwa C Akinboyo, et al.
Cancer|December 30, 2022
ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemiaWen Shuai, Zhuang Zuo, Nianyi Li, et al.
Leukemia & Lymphoma|August 11, 2011
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemiaMark C Lanasa, Patricia H Davis, Michael Datto, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Molecular Genetics and Metabolism|January 7, 2014
Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 geneDeeksha S Bali, Jennifer L Goldstein, Keri Fredrickson, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 19, 2012
Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniquesSarah P Young, Monique Piraud, Jennifer L Goldstein, et al.
American Journal of Clinical Pathology|December 12, 2017
Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 CasesBin Wu, Kimberly Ingersoll, Rachel Jug, et al.
The Journal of Pediatrics|October 14, 2019
Clinical and Molecular Disease Spectrum and Outcomes in Patients with Infantile-Onset Pompe DiseaseNeerja Gupta, Zoheb B Kazi, Sheela Nampoothiri, et al.
Human Pathology|February 26, 2014
Composite lymphoid neoplasm of B-cell and T-cell origins: a pathologic study of 14 casesEndi Wang, Paulie Papavassiliou, Alun R Wang, et al.
International Journal of Laboratory Hematology|April 13, 2021
Infantile leukemia-What factors determine its distinct biological nature? Clinicopathological study of 78 casesXin Liu, Yue Zhao, Catherine Luedke, et al.
American Journal of Clinical Pathology|March 18, 2011
Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literatureEndi Wang, Charles Blake Hutchinson, Qin Huang, et al.
Infection Control and Hospital Epidemiology|August 4, 2020
Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence areaSarah S Lewis, Becky A Smith, Ibukunoluwa C Akinboyo, et al.
Cancer|December 30, 2022
ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemiaWen Shuai, Zhuang Zuo, Nianyi Li, et al.
Leukemia & Lymphoma|August 11, 2011
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemiaMark C Lanasa, Patricia H Davis, Michael Datto, et al.
Pageof 5